Keyphrases
Clinical Evidence
100%
Polymer-based
100%
Drug-eluting Stent
100%
Paclitaxel-eluting Stent
100%
Sirolimus-eluting Stent
100%
Restenosis
28%
Stent
14%
Clinical Research
14%
Clinical Manifestations
14%
Coronary Artery Disease
14%
Cipher
14%
Percutaneous Coronary Intervention
14%
Drug Safety
14%
Antiproliferative Activity
14%
Anti-inflammatory Agents
14%
Approved Drugs
14%
Reintervention
14%
U.S. Food
14%
Long-term Safety
14%
Local Application
14%
Patients with Coronary Artery Disease
14%
Stent Thrombosis
14%
Taxus
14%
Dual Antiplatelet Therapy
14%
Coated Stent
14%
Neointima
14%
Permanent Polymer
14%
Stent Coating
14%
All-subsets
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Coronary Artery Disease
100%
Restenosis
100%
Rapamycin
100%
Clinical Research
50%
Antiplatelet
50%
Antiinflammatory Agent
50%
Stent Thrombosis
50%
Taxus
50%
Neointima
50%
Medicine and Dentistry
Rapamycin
100%
Drug-Eluting Stent
100%
Paclitaxel
100%
Coronary Artery Disease
28%
Restenosis
28%
Clinical Research
14%
Percutaneous Coronary Intervention
14%
Antiplatelet
14%
Antiinflammatory Agent
14%
Stent Thrombosis
14%
Neointima
14%